|
Resolution: standard / high Figure 1.
Gating and control rationale for CD20+ T-cell selection. (A) (i) Typical flow cytometry dot plot of the forward and side scatter of peripheral
blood mononuclear cells (PBMCs). (ii) Dot plot of P1 gated cells (as indicated in
A) stained with CD20-FITC and CD19-PE and shown in 'R2'. (iii) Dot plot of P1 gated
cells, except 'R2', stained with CD20-FITC and CD3-CyQ. (B) (i) Typical flow cytometry dot plot of the forward and side scatter of PBMCs. (ii)
Dot plot of P1 gated cells stained with isotype control IgG-FITC and isotype control
IgG-PE and shown in 'R2' (iii). Dot plot of P1 gated cells, except 'R2', stained with
isotype control IgG-FITC and isotype control CD3-CyQ. (C) (i) Typical flow cytometry dot plot of the forward and side scatter of PBMCs. (ii)
Dot plot of P1 gated cells stained with CD20-FITC and CD19-PE post-RTX treatment and
shown in 'R2'. (iii) Dot plot of P1 gated cells, except 'R2', stained with CD20-FITC
and CD3-CyQ post-RTX incubation.
Eggleton et al. Arthritis Research & Therapy 2011 13:R208 doi:10.1186/ar3541 |